Product Program year 2024 Source: CMS Open Payments

Aemcolo

Drug Antibiotic

NDC 57841-1200-1

Open in the dashboard

General payments

$141,961

7,859 payments

Research payments

$0

0 payments

Through program year 2024, $141,961 in general payments and $0 in research payments were reported against Aemcolo (Antibiotic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $3,640 213
2023 General $35,299 2,165
2022 General $8,470 700
2021 General $37,744 2,689
2020 General $56,809 2,092

Breakdown

Who paid General payments · program years 2020–2024
  1. RedHill Biopharma Inc. $141,961 7,859 payments
Top recipients General payments · program year 2024
  1. Zuselt Zirio Nurse Practitioner, Family · Doral, FL $117 3% · 13 payments
  2. Jorge Suarez Gastroenterology · Doral, FL $87 2% · 4 payments
  3. Francisco Vazquez General Practice · Fort Myers, FL $72 2% · 4 payments
  4. Vanessa Sostre Santiago Gastroenterology · Doral, FL $65 2% · 3 payments
  5. Kristen Nieves Nurse Practitioner, Adult Health · Miami, FL $58 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Gastroenterology Internal Medicine $1,747 49% · 75 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $575 16% · 18 practitioners
  3. Physician Assistant $248 7% · 12 practitioners
  4. Nurse Practitioner, Adult Health Nurse Practitioner $217 6% · 5 practitioners
  5. Internal Medicine $130 4% · 5 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Florida $3,159 87% · 124 recipients
  2. New Jersey $182 5% · 10 recipients
  3. Texas $124 3% · 3 recipients
  4. Colorado $46 1% · 3 recipients
  5. Connecticut $39 1% · 2 recipients

The top 5 of 9 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

7,859 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record